Literature DB >> 27059786

Anticancer effect of a Kampo preparation Daikenchuto.

Takuya Nagata1, Kazufumi Toume2, Lv Xiao Long3, Katsuhisa Hirano3, Toru Watanabe3, Shinichi Sekine3, Tomoyuki Okumura3, Katsuko Komatsu2, Kazuhiro Tsukada3.   

Abstract

No traditional Japanese and Chinese herbal preparations have been shown to be effective antitumor agents, and a Japanese herbal therapy (Kampo medicine) for cancer that causes fewer adverse drug reactions than orthodox pharmaceuticals is desired. Our present study demonstrated that a Kampo preparation Daikenchuto (DKT) exerts an antitumor effect against various cancer cells. We also discovered an antitumor factor in Japanese Zanthoxylum peel, which is an ingredient of DKT. Breast, esophageal, gastric, and colon cancer cell lines were individually incubated with DKT for 1-72 h, followed by assessment of tumor growth inhibition by MTT assay. The cancer cells were also analyzed for apoptotic changes after DKT treatment. Nude mice were used to establish a model of gastric cancer tumor growth and peritoneal disseminated metastasis, in which the number of peritoneal disseminations was evaluated after oral administration of DKT for 4 weeks. In addition, the antitumor effects of the individual DKT ingredients (viz., ginseng, Japanese Zanthoxylum peel, and processed ginger) and other Kampo preparations were also analyzed. The antitumor effect of DKT was demonstrated in gastric, breast, esophageal, and colon cancer cells. DKT treatment induced apoptosis in these cells. Oral administration of DKT had a tendency to reduce the growth and significantly reduced the peritoneal dissemination of gastric cancer in the nude mouse model compared with control. DKT exhibited a higher antitumor effect than other Kampo preparations. Furthermore, Japanese Zanthoxylum peel, an ingredient of DKT, showed a particularly potent antitumor effect. Our study indicated that DKT is useful as a Kampo preparation for cancer therapy. We also showed that Japanese Zanthoxylum peel, an ingredient of DKT, contains an antitumor factor.

Entities:  

Keywords:  Daikenchuto (DKT); Japanese Zanthoxylum peel; Kampo medicines

Mesh:

Substances:

Year:  2016        PMID: 27059786     DOI: 10.1007/s11418-016-0989-x

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  13 in total

1.  Effect of Dai-kenchu-to on levels of 3 brain-gut peptides (motilin, gastrin and somatostatin) in human plasma.

Authors:  T Nagano; H Itoh; M Takeyama
Journal:  Biol Pharm Bull       Date:  1999-10       Impact factor: 2.233

2.  Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.

Authors:  Xiaojuan Shu; Michael McCulloch; Hang Xiao; Michael Broffman; Jin Gao
Journal:  Integr Cancer Ther       Date:  2005-09       Impact factor: 3.279

3.  Can Kampo therapy prolong the life of cancer patients?

Authors:  Yoshihiro Takegawa; Hitoshi Ikushima; Kyousuke Ozaki; Shunsuke Furutani; Takashi Kawanaka; Takaharu Kudoh; Masafumi Harada
Journal:  J Med Invest       Date:  2008-02

Review 4.  Exodus of Kampo, traditional Japanese medicine, from the complementary and alternative medicines: is it time yet?

Authors:  Toru Kono; Takashi Kanematsu; Masaki Kitajima
Journal:  Surgery       Date:  2009-07-29       Impact factor: 3.982

5.  Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways.

Authors:  Yang Yang; Takayuki Ikezoe; Tamotsu Takeuchi; Yoshihiro Adachi; Yuji Ohtsuki; H Phillip Koeffler; Hirokuni Taguchi
Journal:  Oncol Rep       Date:  2006-06       Impact factor: 3.906

6.  The herbal medicine Dai-Kenchu-Tou stimulates upper gut motility through cholinergic and 5-hydroxytryptamine 3 receptors in conscious dogs.

Authors:  C Shibata; I Sasaki; H Naito; T Ueno; S Matsuno
Journal:  Surgery       Date:  1999-11       Impact factor: 3.982

Review 7.  A Kampo medicine "Juzen-taiho-to"--prevention of malignant progression and metastasis of tumor cells and the mechanism of action.

Authors:  I Saiki
Journal:  Biol Pharm Bull       Date:  2000-06       Impact factor: 2.233

8.  Colonic vascular conductance increased by Daikenchuto via calcitonin gene-related peptide and receptor-activity modifying protein 1.

Authors:  Toru Kono; Takashi Koseki; Shinichi Chiba; Yoshiaki Ebisawa; Naoyuki Chisato; Jun Iwamoto; Shinichi Kasai
Journal:  J Surg Res       Date:  2008-04-10       Impact factor: 2.192

9.  Suppressive effect of juzentaihoto on vascularization induced by b16 melanoma cells in vitro and in vivo.

Authors:  Shintaro Ishikawa; Takako Ishikawa; Kazuhito Asano; Hiroshi Fujiwara; Mayumi Okada; Masataka Sunagawa; Tadashi Hisamitsu
Journal:  Evid Based Complement Alternat Med       Date:  2011-10-27       Impact factor: 2.629

10.  IL-12 and IL-18 induction and subsequent NKT activation effects of the Japanese botanical medicine Juzentaihoto.

Authors:  Kazuhiko Fujiki; Masanori Nakamura; Takako Matsuda; Mariko Isogai; Minako Ikeda; Yutaka Yamamoto; Mari Kitamura; Naoko Sazaki; Fumiatsu Yakushiji; Shinji Suzuki; Junji Tomiyama; Takashi Uchida; Ken Taniguchi
Journal:  Int J Mol Sci       Date:  2008-07-08       Impact factor: 6.208

View more
  2 in total

Review 1.  Recent Advances in Herbal Medicines for Digestive System Malignancies.

Authors:  Jiyao Sheng; Xiaohan Zou; Ziqian Cheng; Yien Xiang; Wei Yang; Yang Lin; Ranji Cui
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

2.  The inhibitory effect of TU-100 on hepatic stellate cell activation in the tumor microenvironment.

Authors:  Yuma Wada; Kazunori Tokuda; Yuji Morine; Shohei Okikawa; Shoko Yamashita; Tetsuya Ikemoto; Satoru Imura; Yu Saito; Shinichiro Yamada; Mitsuo Shimada
Journal:  Oncotarget       Date:  2020-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.